Limited Population Pathway for Antibacterial and Antifungal Drugs Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 5, 2020
August 5, 2020
f01d33af-ed26-4eb5-961a-03e00c90f2c7
Related Documents
M12 Drug Interaction Studies
Guidance DocumentAugust 2, 2024Center for Drug Evaluation and Research
Bacterial Vaginosis: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentAugust 1, 2019Center for Drug Evaluation and Research
Qualification Process for Drug Development Tools Guidance for Industry and FDA Staff
Guidance DocumentNovember 24, 2020Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox